Literature DB >> 33475676

Rice bran modulates renal disease risk factors in animals submitted to high sugar-fat diet.

Juliana Silva Siqueira1, Fabiane Valentini Francisqueti-Ferron2, Jéssica Leite Garcia2, Carol Cristina Vágula de Almeida Silva2, Mariane Róvero Costa2, Erika Tiemi Nakandakare-Maia2, Fernando Moreto2, Ana Lúcia A Ferreira2, Igor Otávio Minatel1, Artur Junio Togneri Ferron2, Camila Renata Corrêa2.   

Abstract

INTRODUCTION: Obesity, diabetes, and hypertension are common risk factors for chronic kidney disease (CKD). CKD arises due to many pathological insults, including inflammation and oxidative stress, which affect renal function and destroy nephrons. Rice bran (RB) is rich in vitamins and minerals, and contains significant amount of antioxidants. The aim of this study was to evaluate the preventive effect of RB on renal disease risk factors.
METHODS: Male Wistar rats (±325 g) were divided into two experimental groups to received a high sugar-fat diet (HSF, n = 8) or high sugar-fat diet with rice bran (HSF + RB, n = 8) for 20 weeks. At the end, renal function, body composition, metabolic parameters, renal inflammatory and oxidative stress markers were analyzed.
RESULTS: RB prevented obesity [AI (HSF= 9.92 ± 1.19 vs HSF + RB= 6.62 ± 0.78)], insulin resistance [HOMA (HSF= 83 ± 8 vs. HSF + RB= 42 ± 11)], dyslipidemia [TG (HSF= 167 ± 41 vs. HSF + RB=92 ± 40)], inflammation [TNF-α (HSF= 80 ± 12 vs. HSF + RB=57 ± 14), IL-6 (903 ± 274 vs. HSF + RB=535 ± 277)], oxidative stress [protein carbonylation (HSF= 3.38 ± 0.18 vs. HSF + RB=2.68 ± 0.29), RAGE (HSF=702 ± 36 vs. RSF + RB=570 ± 190)], and renal disease [protein/creatinine ratio (HSF=1.10 ± 0.38 vs. HSF + RB=0.49 ± 0.16)].
CONCLUSION: In conclusion, rice bran prevented renal disease by modulating risk factors.

Entities:  

Year:  2021        PMID: 33475676      PMCID: PMC8257273          DOI: 10.1590/2175-8239-JBN-2020-0169

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


Introduction

Chronic kidney disease (CKD) is defined as changes in the kidney function or structure for more than three months, independent of the cause, which affect the health of an individual1. Epidemiological data show that CKD affects 10-16% of adults in the world2, being considered a global health problem. CKD diagnosis is usually established by the glomerular filtration rate (GFR). However, the reference GFR range does not exclude renal disease, since renal disease leads to decrease of renal function. Within this context, the National Kidney Foundation recommends proteinuria analysis for early stage detection and GFR estimations for assessing the progression of kidney disease3. Obesity, diabetes, and hypertension are common risk factors for CKD4. CKD arises due to many pathological insults, including inflammation and oxidative stress, which affect the renal function and destroy nephrons. The literature reports an association between renal impairment and different mediators of inflammation including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) suggesting that CKD is a low-grade inflammatory process5 , 6. Oxidative stress can be considered an imbalance in the reactive oxygen species (ROS) production/degradation ratio. Excessive ROS levels can produce cellular damage by interacting with biomolecules (proteins, lipids, and nucleic acids) resulting in negative effects on tissue function and structure, including kidney. Studies show that increased oxidative stress markers, as malondialdehyde (MDA) and carbonylated protein are inversely correlated with kidney function5 , 7. As a result, the nephrons compensate the function of injured nephrons with hyperfiltration, leading to glomerular hypertension, proteinuria, and eventually loss of renal function overt time1. Several mechanisms are associated with renal inflammation and oxidative stress. When activated, the receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily of cell surface receptors, leads to a signalling sequence with the activation of the nuclear factor kappa-B (NFκB) resulting in proinflammatory cytokines production, such as TNF-α, IL-6, and monocyte chemoattractant protein-1 (MCP-1)8. RAGE activation can also directly induce oxidative stress by activating nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase (NOX), especially NOX-4. Thus, RAGE activation is an interface between oxidative stress and inflammation, which are pillars for development of several diseases, especially in organs that express these AGE receptors, as brain, heart, and kidneys9. In this context, an interest has emerged on the role of functional foods to prevent some diseases. Rice bran is one of the most abundant products produced in the rice milling industry that is rich in vitamins, including vitamin E, thiamin, niacin, and minerals like aluminum, calcium, chlorine, iron, magnesium, manganese, phosphorus, potassium, sodium, and zinc. It also contains a significant amount of antioxidants such as tocopherols, tocotrienols, and oryzanol. Rice bran also has proteins of high nutritional value and it is a good source of both soluble and insoluble dietary fiber10. Thus, considering that the consumption of high sugar-fat diet can lead to obesity and kidney disease risk factors development and the lack of studies regarding the effect of rice bran on these physiopathological aspects, the aim of this study was to evaluate the effect of rice bran on the modulation of renal disease risk factors in animals submitted to high sugar-fat diet.

Material and methods

Animals and experimental protocol

In the present study, male Wistar rats (±325 g) from the Animal Center of Botucatu Medical School, Sao Paulo State University (UNESP, Botucatu, SP, Brazil), were divided into two experimental groups to receive high sugar-fat diet (HSF, n = 8) or high sugar-fat diet with rice bran (HSF + RB, n = 8) for 20 weeks. The diets and water were provided ad libitum. The diet composition has been described in our previous study11. All the animals were housed in an environmentally controlled room (22±3 ºC, 12 h light-dark cycle and relative humidity of 60±5%). All of the experiments were performed in accordance with the Canadian Council on Animal Care (CCAC)12 and the procedures were approved by the Animal Ethics Committee of Botucatu Medical School (1305/2019). In order to confirm the effects of high sugar-fat diet on renal risk factors development in the HSF group, male Wistar (n=8, ±325 g, and same age), fed a standard diet, were used as reference group (baseline control group). At the end of the experiment, the animals were euthanized by decapitation after anesthesia with thiopental (120 mg/kg, intraperitoneal injection) and all efforts were made to minimize suffering. Blood from fasted animals was collected in tubes containing EDTA and centrifuged at 3500 rpm and the plasma was collected for analysis. Fat deposits and kidneys were collected for analysis.

Rice bran dose

Since rice bran contains antinutritionals components, such as lipases and trypsin inhibitors10, it was subjected to a stabilization process, which consisted of heating in an oven to 100ºC, for 4 minutes. After the stabilization process, it was mixed to the chow in a dose of 11% (w/w). The dose has been chosen based on previous studies13.

Nutritional parameters

The nutritional parameters evaluated were: chow intake, water intake, and caloric intake. Caloric intake was determined by multiplying the energy value of each diet (g × Kcal) by the daily food consumption plus the calories from water (0.25 × 4 × mL consumed).

Body composition

Body composition was evaluated considering the final body weight (FBW), and adiposity index (AI). After euthanasia, fat tissues (visceral (VAT), epididymal (EAT), and retroperitoneal (RAT)) were used to calculate the AI by the following formula: 14.

Metabolic analysis

After 8 h fasting, blood was collected and the plasma was used to measure the biochemical parameters. Glucose concentration was determined using a glucometer (Accu-Chek Performa, Roche Diagnostics Brazil Limited) and triglycerides were measured with an automatic enzymatic analyzer system (Chemistry Analyzer BS-200, Mindray Medical International Limited, Shenzhen, China). The insulin level was measured using the enzyme-linked immunosorbent assay (ELISA) method using commercial kits (EMDMillipore Corporation, Billerica, MA, USA). The homeostatic model of insulin resistance (HOMA-IR) was used as an insulin resistance index, calculated according to the formula: HOMA-IR = (fasting glucose (mmol/L) x fasting insulin (µU/mL))/22.515.

Systolic blood pressure

Systolic blood pressure (SBP) was assessed in conscious rats by the noninvasive tail-cuff method with a Narco Bio-Systems® electrosphygmomanometer (International Biomedical, Austin, TX, USA). The animals were kept in a wooden box (50 × 40 cm) between 38 and 40°C for 4-5 minutes to stimulate arterial vasodilation16. After this procedure, a cuff with a pneumatic pulse sensor was attached to the tail of each animal. The cuff was inflated to 200 mmHg pressure and subsequently deflated. The blood pressure values were recorded on a Gould RS 3200 polygraph (Gould Instrumental Valley View, Ohio, USA). The average of three pressure readings was recorded for each animal.

Renal inflammation

Renal tissue (±150 mg) was homogenized (ULTRA-TURRAX® T 25 basic IKA® Werke, Staufen, Germany) in 1.0 mL of phosphate-buffered saline (PBS) pH 7.4 in cold solution and centrifuged at 800 g at 4°C for 10 min. The supernatant (100 µL) was used in the analysis. TNF-α and IL-6 levels were measured using the ELISA method with commercial kits from R&D System, Minneapolis, USA. The supernatant (100 µL) was used for analysis, and the results were corrected by the protein amount.

Renal malondialdehyde levels (mda)

MDA level was used to evaluate the lipid peroxidation. Briefly, 250 µL of epididymal adipose tissue supernatant was used plus 750 µL of 10% trichloroacetic acid for precipitation of proteins. Samples were centrifuged (3000 rpm, for 5 minutes; Eppendorf® Centrifuge 5804-R, Hamburg, Germany) and the supernatant removed. Thiobarbituric acid (TBA) was added 0.67% in ratio (1:1) and the samples heated for 15 minutes at 100°C. MDA reacts with TBA in the 1:2 (MDA:TBA) ratio. After cooling, the reading at 535nm was performed on Spectra Max 190 microplate reader (Molecular Devices®, Sunnyvale, CA, USA). The MDA concentration was obtained by the molar extinction coefficient (1.56 x 105 M-1·cm-1) and the absorbance of the samples and the final result reported in nmol/g protein17.

Renal protein carbonylation

Carbonylated proteins were measured by an unspecific method that uses DNPH (2,4-dinitrophenylhydrazine derivatizing agent) and photometric detection of any modified protein by carbonylation. Carbonylated protein levels are reported in nmol of DNPH/mg of protein18.

Rage levels

Renal tissue (±150 mg) was homogenized (ULTRA-TURRAX® T 25 basic IKA® Werke, Staufen, Germany) in 1.0 mL of phosphate-buffered saline (PBS) pH 7.4 in cold solution and centrifuged at 800 g at 4°C for 10 min. The supernatant (100 µL) was used in the analysis. RAGE levels were measured with ELISA method using commercial kits from R&D System, Minneapolis, USA. The results were corrected according to the protein amount.

Renal function

At 24 hours, urine was collected from the metabolic cages to measure the excretion of creatinine and the total protein. All analyses were performed with an automatic enzymatic analyzer system (biochemical analyzer BS-200, Mindray, China). The glomerular filtration rate (GFR = (urine creatinine × flux)/plasma creatinine) and proteinuria (protein/creatinine ratio) were also calculated.

Statistical analysis

The data were submitted to Kolmogorov-Smirnov normality test. Parametric variables were compared by Student’s t-test and the results are reported as mean ± standard deviation. Non-parametric variables were compared by Mann-Whitney test and the results are reported as median (interquartile range (25-75)). Pearson correlation was used to assess the association among parameters. Statistical analyses were performed using Sigma Stat for Windows Version 3.5 (Systat Software Inc., San Jose, CA, USA). A p value < 0.05 was considered statistically significant.

Results

Rice bran effect on nutritional parameters

The nutritional parameters are presented in the Figure 1. It is possible to note the chow, water, and caloric intake in the HSF and HSF + RB groups. The HSF + RB showed lower final body weight and adiposity index than the HSF group.
Figure 1.

Nutritional parameters. A, Chow fed (g/day); B, Water intake (mL/day); C, Caloric intake (kcal/day); D, Final body weight (g); E, Adiposity index (%). Comparison by Student’s t-test or Mann-Whitney test, n=8 animals/group. p < 0.05 was considered significant. HSF: high sugar-fat diet; RB: rice bran. NS: not significant.

Rice bran effect on renal cardiometabolic risk factors

Renal cardiometabolic risk factors are presented in the Figure 2. It is possible to verify reduced HOMA-IR and triglycerides in the HSF + RB group compared to HSF. No rice bran effect was observed on systolic blood pressure.
Figure 2.

Renal cardiometabolic risk factors. A, Systolic blood pressure (mmHg); B, HOMA- IR; C, Triglycerides (mg/dL). Comparison by Student’s t-test or Mann-Whitney test, n=8 animals/group. p < 0.05 was considered significant. HSF: high sugar-fat diet; RB: rice bran. NS: not significant.

Rice bran effect on renal inflammation

Kidney inflammation parameters are presented in the Figure 3. Rice bran was effective to reduce inflammation, since the HSF + RB showed lower TNF-α and IL-6 levels compared to HSF.
Figure 3.

Renal inflammation parameters. A, Tumor necrosis factor alpha (TNF-α, pg/g protein); B, Interleukin-6 (IL-6, pg/g protein). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Rice bran effect on renal oxidative stress

Figure 4 shows the oxidative stress parameters. The group HSF + RB presented lower protein carbonylation and RAGE level compared to the HSF. No difference was observed for the MDA levels.
Figure 4.

Renal oxidative stress parameters. A, Protein carbonylation (nmol/mg protein) B, Malondialdehyde (nmom/mg protein); C, RAGE (pg/g protein). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Malondialdehyde (nmom/mg protein); C, RAGE (pg/g protein). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Renal function parameters

Figure 5 presents the renal function parameters. It is possible to verify the proteinuria presence in the HSF group while the HSF + RB was protected. No difference was observed for the glomerular filtration rate between HSF and HSF + RB groups.
Figure 5.

Renal function evaluation. A, Protein/creatinine ratio; B, Glomerular filtration rate (GFR, mL/min). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Correlation among the parameters

A positive correlation was found between proteinuria and caloric intake, adiposity index, triglycerides, HOMA, and carbonylation. Regarding the GFR, there was a positive correlation with MDA and a negative correlation with TNF-α (Figure 6).
Figure 6.

Pearson correlation among the variables. Red values indicate negative significant difference, gray values indicate non-significant difference, and blue values indicate positive significant correlation.

Discussion

The study aimed to evaluate the effect of rice bran on the modulation of renal damage risk factors. Kidney disease has a major effect on global health, both as a direct cause of morbidity and mortality and as an important risk factor for cardiovascular disease. Moreover, CKD is preventable and treatable and deserves greater attention in global health policy decision making19. Thus, the discovery of natural products, as rice bran, able to prevent this condition is extremely relevant. In the present study, a beneficial effect of rice bran was observed on the main renal disease risk factors. At the same time, the HSF group showed proteinuria and several risk factors for kidney injury, among them: obesity, dyslipidemia, insulin resistance, inflammation, and oxidative stress4. The literature is scarce of studies with rice bran and CKD. One study published by our research group found that γOz, the main bioactive compound of rice bran, was effective to recover obesity-induced kidney disease after 10 weeks of treatment in Wistar rats20. Another experimental study by Al-Okbi et al.21 found that γ-oryzanol (γ-O) and rice bran oil/γ-O mixture (RBO/γ-O) had protective effects on cardiovascular diseases and cardiorenal syndrome, similar to Francisqueti et al.22, which found a protective effect of γOz on cardiorenal metabolic syndrome. Obesity has been identified as one of the main cause of kidney disease since it is associated with hemodynamic, structural, and histopathological alterations in the kidney, as well as metabolic and biochemical alterations that predispose to kidney disease23 , 24. The animals that received rice bran presented the same chow, water, and caloric intake, however lower final body weight and adiposity index than the HSF group. Although the mechanism by which rice bran protects against obesity is not clarified, the literature confirms this antiobesogenic effect and attributes the benefits to dietary fiber, oligosaccharides, hemicelluloses, and non-starchy polysaccharides as well as some water-soluble phytochemicals present in the rice bran25. Obesity is the main risk factor for the development of chronic diseases, such as type 2 diabetes and cardiovascular diseases, which increases the risk for CKD26. Hyperglycemia increases the non-enzymatic reaction of glucose and other glycating compounds derived both from glucose and from increased fatty acid oxidation, which generates advanced glycation end products in complication-prone cell types, including kidney cells27. The HSF group not only developed obesity but also insulin resistance. However, the animals that received rice bran did not present insulin resistance, which can be explained by the protection against obesity in the HSF + RB group. An excessive adipose tissue is associated with a chronic low-grade inflammation that may explain the development of the obesity-related pathologies, such as type 2 diabetes mellitus28 , 29. Hypertension is a major risk factor for renal disease30. Multiple mechanisms are involved in determination of renal damage in hypertension, such as the renin-angiotensin-aldosterone system (RAAS), oxidative stress, endothelial dysfunction, and inflammation31. In the present study, no effect of rice bran was observed on systolic blood pressure. However, the HSF + RB group presented protection against kidney damage, which can be explained by the effect on inflammation and oxidative stress. The main bioactive compound in RB is gamma-oryzanol, which has demonstrated antioxidative and anti-inflammatory effects25 , 32 also in kidneys of obese animals20. The upregulation of pro-inflammatory cytokines, as IL-6 and TNF-α, mediated by AGE/RAGE and NFκB, increase oxidative stress, which leads to local and systemic inflammation, glomerular and tubular lesions, and proteinuria. Among cytokines, TNF-α is known to cause direct cytotoxicity and apoptosis of renal cells33 , 34. Oxidized molecules reflect the damage mediated by oxidative stress in cells and tissues, and their measurement can be indicative of oxidative stress in a specific disease, as well as the potential efficacy of clinical treatments. Some of these modifications, as carbonylation, are irreversible and can lead to altered protein expression and activity, resulting in organ impairment35. Confirming the antioxidant and anti-inflammatory effect of rice bran, the HSF + RB animals showed reduced TNF-α, IL-6, RAGE, protein carbonylation, and proteinuria compared to the HSF group. In summary, rice bran was able to prevent obesity, insulin resistance, dyslipidemia, inflammation, oxidative stress, and renal disease. These findings provide important information about the use of bioactive compounds as alternative therapeutics for preventing renal disease and associated risk factors. However, since the main limitation of this study was not evaluating the pathways involved in the positive effects of rice bran, more studies are necessary. Therefore, we concluded that rice bran was able to prevent renal disease by modulating risk factors.
  32 in total

Review 1.  Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.

Authors:  S Mennuni; S Rubattu; G Pierelli; G Tocci; C Fofi; M Volpe
Journal:  J Hum Hypertens       Date:  2013-06-27       Impact factor: 3.012

2.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

3.  Simplified 2,4-dinitrophenylhydrazine spectrophotometric assay for quantification of carbonyls in oxidized proteins.

Authors:  Cristina S Mesquita; Raquel Oliveira; Fátima Bento; Dulce Geraldo; João V Rodrigues; João C Marcos
Journal:  Anal Biochem       Date:  2014-05-06       Impact factor: 3.365

Review 4.  Evaluation of proteinuria and GFR to diagnose and classify kidney disease: systematic review and proof of concept.

Authors:  Axel Regeniter; Heike Freidank; Michael Dickenmann; Wolf H Boesken; Werner H Siede
Journal:  Eur J Intern Med       Date:  2009-04-10       Impact factor: 4.487

Review 5.  Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease.

Authors:  Victoria Cachofeiro; Marian Goicochea; Soledad García de Vinuesa; Pilar Oubiña; Vicente Lahera; José Luño
Journal:  Kidney Int Suppl       Date:  2008-12       Impact factor: 10.545

Review 6.  Rice bran: a novel functional ingredient.

Authors:  Mian Kamran Sharif; Masood Sadiq Butt; Faqir Muhammad Anjum; Saima Hafiz Khan
Journal:  Crit Rev Food Sci Nutr       Date:  2014       Impact factor: 11.176

Review 7.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

8.  Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet.

Authors:  Fabiane Valentini Francisqueti; Igor Otávio Minatel; Artur Junio Togneri Ferron; Silméia Garcia Zanati Bazan; Vanessa Dos Santos Silva; Jéssica Leite Garcia; Dijon Henrique Salomé de Campos; Ana Lúcia Ferreira; Fernando Moreto; Antonio Carlos Cicogna; Camila Renata Corrêa
Journal:  Nutrients       Date:  2017-11-29       Impact factor: 5.717

Review 9.  Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases.

Authors:  Rosa Vona; Lucrezia Gambardella; Camilla Cittadini; Elisabetta Straface; Donatella Pietraforte
Journal:  Oxid Med Cell Longev       Date:  2019-05-05       Impact factor: 6.543

10.  Gamma Oryzanol Treats Obesity-Induced Kidney Injuries by Modulating the Adiponectin Receptor 2/PPAR-α Axis.

Authors:  Fabiane Valentini Francisqueti; Artur Junio Togneri Ferron; Fabiana Kurokawa Hasimoto; Pedro Henrique Rizzi Alves; Jéssica Leite Garcia; Klinsmann Carolo Dos Santos; Fernando Moreto; Vanessa Dos Santos Silva; Ana Lúcia A Ferreira; Igor Otávio Minatel; Camila Renata Corrêa
Journal:  Oxid Med Cell Longev       Date:  2018-09-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.